BRENDA - Reference to 2.7.1.74; Id = 721556

aphidicolin

increases dCK activity via Ser74 phosphorylation, effect of aphidicolin treatment on dCK activity in leukemic cells with substrate deoxycytidine and cladribine and other substrates, overview

Homo sapiens

additional information

deoxycytidine kinase is a key enzyme in the activation of several therapeutic nucleoside analogues

Homo sapiens

S74E

site-directed mutagenesis, the mutation sensitizes the enzyme to feedback inhibition by dCTP, regardless of the phosphoryl donor. Mimicking Ser74 phosphorylation by a S74E mutation increases the enzyme activity toward pyrimidine analogues. The S74E mutation increased the kcat for cladribine by 8 or 3fold, depending on whether the phosphoryl donor was ATP or UTP, for clofarabine by about 2fold with both ATP and UTP, and for fludarabine by 2fold, but only with UTP

Homo sapiens

dCTP

a potent inhibitor of the enzyme when ATP is the phosphoryl donor, but a relatively weak inhibitor when the enzyme activity is measured with UTP as the phosphoryl donor. Inhibition is higher with respect to cladribine than deoxycytidine

Homo sapiens

0.00007

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.00009

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.00018

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.00027

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.00065

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0016

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.0024

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.0087

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0155

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.0155

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.022

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.028

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0325

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.142

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.45

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.551

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

cytosol

-

Homo sapiens

5829

-

Mg2+

required

Homo sapiens

ATP + cladribine

Homo sapiens

-

ADP + cladribine 5'-phosphate

-

?

ATP + clofarabine

Homo sapiens

-

ADP + clofarabine 5'-phosphate

-

?

ATP + deoxyadenosine

Homo sapiens

-

ADP + dAMP

-

?

ATP + deoxycytidine

Homo sapiens

-

ADP + dCMP

-

?

ATP + deoxyguanosine

Homo sapiens

-

ADP + dGMP

-

?

ATP + fludarabine

Homo sapiens

-

ADP + fludarabine 5'-phosphate

-

?

UTP + cladribine

Homo sapiens

-

UDP + cladribine 5'-phosphate

-

?

UTP + clofarabine

Homo sapiens

-

UDP + clofarabine 5'-phosphate

-

?

UTP + deoxyadenosine

Homo sapiens

-

UDP + dAMP

-

?

UTP + deoxycytidine

Homo sapiens

-

UDP + dCMP

-

?

UTP + deoxyguanosine

Homo sapiens

-

UDP + dGMP

-

?

UTP + fludarabine

Homo sapiens

-

UDP + phospho-fludarabine

-

?

Homo sapiens

-

phosphoprotein

phosphorylation of deoxycytidine kinase on Ser74 increases the enzyme activity, increasing dCK activity via Ser74 phosphorylation, e.g. by aphidicolin, can enhance the intracellular activation of some nucleoside analogs, like gemcitabine, but not of cladribine or fludarabine, overview

Homo sapiens

chronic lymphocytic leukemia cell

-

Homo sapiens

-

HCT-116 cell

-

Homo sapiens

-

HT-29 cell

-

Homo sapiens

-

leukemia cell

-

Homo sapiens

-

ATP + cladribine

-

721556

Homo sapiens

ADP + cladribine 5'-phosphate

-

?

ATP + clofarabine

-

721556

Homo sapiens

ADP + clofarabine 5'-phosphate

-

?

ATP + deoxyadenosine

-

721556

Homo sapiens

ADP + dAMP

-

?

ATP + deoxycytidine

-

721556

Homo sapiens

ADP + dCMP

-

?

ATP + deoxyguanosine

-

721556

Homo sapiens

ADP + dGMP

-

?

ATP + fludarabine

-

721556

Homo sapiens

ADP + fludarabine 5'-phosphate

-

?

additional information

deoxycytidine kinase shows broad substrate specificity, catalyzing the phosphorylation of deoxycytidine, deoxyadenosine, and deoxyguanosine with ATP or UTP as phosphoryl donor

721556

Homo sapiens

?

-

UTP + cladribine

-

721556

Homo sapiens

UDP + cladribine 5'-phosphate

-

?

UTP + clofarabine

-

721556

Homo sapiens

UDP + clofarabine 5'-phosphate

-

?

UTP + deoxyadenosine

-

721556

Homo sapiens

UDP + dAMP

-

?

UTP + deoxycytidine

-

721556

Homo sapiens

UDP + dCMP

-

?

UTP + deoxyguanosine

-

721556

Homo sapiens

UDP + dGMP

-

?

UTP + fludarabine

-

721556

Homo sapiens

UDP + phospho-fludarabine

-

?

37

-

assay at

Homo sapiens

0.015

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.021

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0804

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.123

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.172

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.177

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.183

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.211

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.363

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.486

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.88

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

1.005

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

1.11

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

1.334

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

1.386

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

2.45

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

7.6

-

assay at

Homo sapiens

ATP

-

Homo sapiens

UTP

-

Homo sapiens

0.0015

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates cladribine and ATP, mixed inhibition

Homo sapiens

0.0029

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates deoxycytidine and ATP, mixed inhibition

Homo sapiens

0.0058

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates cladribine and ATP, mixed inhibition

Homo sapiens

0.027

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates cladribine and UTP, uncompetitive inhibition

Homo sapiens

0.03

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates deoxycytidine and ATP, mixed inhibition

Homo sapiens

0.05

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates cladribine and UTP, uncompetitive inhibition

Homo sapiens

0.052

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates deoxycytidine and UTP, uncompetitive inhibition

Homo sapiens

0.398

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates deoxycytidine and UTP, uncompetitive inhibition

Homo sapiens

aphidicolin

increases dCK activity via Ser74 phosphorylation, effect of aphidicolin treatment on dCK activity in leukemic cells with substrate deoxycytidine and cladribine and other substrates, overview

Homo sapiens

additional information

deoxycytidine kinase is a key enzyme in the activation of several therapeutic nucleoside analogues

Homo sapiens

ATP

-

Homo sapiens

UTP

-

Homo sapiens

S74E

site-directed mutagenesis, the mutation sensitizes the enzyme to feedback inhibition by dCTP, regardless of the phosphoryl donor. Mimicking Ser74 phosphorylation by a S74E mutation increases the enzyme activity toward pyrimidine analogues. The S74E mutation increased the kcat for cladribine by 8 or 3fold, depending on whether the phosphoryl donor was ATP or UTP, for clofarabine by about 2fold with both ATP and UTP, and for fludarabine by 2fold, but only with UTP

Homo sapiens

dCTP

a potent inhibitor of the enzyme when ATP is the phosphoryl donor, but a relatively weak inhibitor when the enzyme activity is measured with UTP as the phosphoryl donor. Inhibition is higher with respect to cladribine than deoxycytidine

Homo sapiens

0.0015

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates cladribine and ATP, mixed inhibition

Homo sapiens

0.0029

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates deoxycytidine and ATP, mixed inhibition

Homo sapiens

0.0058

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates cladribine and ATP, mixed inhibition

Homo sapiens

0.027

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates cladribine and UTP, uncompetitive inhibition

Homo sapiens

0.03

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates deoxycytidine and ATP, mixed inhibition

Homo sapiens

0.05

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates cladribine and UTP, uncompetitive inhibition

Homo sapiens

0.052

-

dCTP

pH 7.6, 37°C, enzyme mutant S74E, with substrates deoxycytidine and UTP, uncompetitive inhibition

Homo sapiens

0.398

-

dCTP

pH 7.6, 37°C, wild-type enzyme, with substrates deoxycytidine and UTP, uncompetitive inhibition

Homo sapiens

0.00007

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.00009

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.00018

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.00027

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.00065

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0016

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.0024

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.0087

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0155

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.0155

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.022

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.028

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0325

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.142

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.45

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.551

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

cytosol

-

Homo sapiens

5829

-

Mg2+

required

Homo sapiens

ATP + cladribine

Homo sapiens

-

ADP + cladribine 5'-phosphate

-

?

ATP + clofarabine

Homo sapiens

-

ADP + clofarabine 5'-phosphate

-

?

ATP + deoxyadenosine

Homo sapiens

-

ADP + dAMP

-

?

ATP + deoxycytidine

Homo sapiens

-

ADP + dCMP

-

?

ATP + deoxyguanosine

Homo sapiens

-

ADP + dGMP

-

?

ATP + fludarabine

Homo sapiens

-

ADP + fludarabine 5'-phosphate

-

?

UTP + cladribine

Homo sapiens

-

UDP + cladribine 5'-phosphate

-

?

UTP + clofarabine

Homo sapiens

-

UDP + clofarabine 5'-phosphate

-

?

UTP + deoxyadenosine

Homo sapiens

-

UDP + dAMP

-

?

UTP + deoxycytidine

Homo sapiens

-

UDP + dCMP

-

?

UTP + deoxyguanosine

Homo sapiens

-

UDP + dGMP

-

?

UTP + fludarabine

Homo sapiens

-

UDP + phospho-fludarabine

-

?

phosphoprotein

phosphorylation of deoxycytidine kinase on Ser74 increases the enzyme activity, increasing dCK activity via Ser74 phosphorylation, e.g. by aphidicolin, can enhance the intracellular activation of some nucleoside analogs, like gemcitabine, but not of cladribine or fludarabine, overview

Homo sapiens

chronic lymphocytic leukemia cell

-

Homo sapiens

-

HCT-116 cell

-

Homo sapiens

-

HT-29 cell

-

Homo sapiens

-

leukemia cell

-

Homo sapiens

-

ATP + cladribine

-

721556

Homo sapiens

ADP + cladribine 5'-phosphate

-

?

ATP + clofarabine

-

721556

Homo sapiens

ADP + clofarabine 5'-phosphate

-

?

ATP + deoxyadenosine

-

721556

Homo sapiens

ADP + dAMP

-

?

ATP + deoxycytidine

-

721556

Homo sapiens

ADP + dCMP

-

?

ATP + deoxyguanosine

-

721556

Homo sapiens

ADP + dGMP

-

?

ATP + fludarabine

-

721556

Homo sapiens

ADP + fludarabine 5'-phosphate

-

?

additional information

deoxycytidine kinase shows broad substrate specificity, catalyzing the phosphorylation of deoxycytidine, deoxyadenosine, and deoxyguanosine with ATP or UTP as phosphoryl donor

721556

Homo sapiens

?

-

UTP + cladribine

-

721556

Homo sapiens

UDP + cladribine 5'-phosphate

-

?

UTP + clofarabine

-

721556

Homo sapiens

UDP + clofarabine 5'-phosphate

-

?

UTP + deoxyadenosine

-

721556

Homo sapiens

UDP + dAMP

-

?

UTP + deoxycytidine

-

721556

Homo sapiens

UDP + dCMP

-

?

UTP + deoxyguanosine

-

721556

Homo sapiens

UDP + dGMP

-

?

UTP + fludarabine

-

721556

Homo sapiens

UDP + phospho-fludarabine

-

?

37

-

assay at

Homo sapiens

0.015

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.021

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.0804

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.123

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.172

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

0.177

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.183

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

0.211

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.363

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

0.486

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

0.88

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

1.005

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

1.11

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

1.334

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

1.386

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

2.45

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

7.6

-

assay at

Homo sapiens

additional information

deoxycytidine kinase is a key enzyme in the activation of several therapeutic nucleoside analogues

Homo sapiens

additional information

deoxycytidine kinase is a key enzyme in the activation of several therapeutic nucleoside analogues

Homo sapiens

1.8

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

2.6

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

3

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

6.4

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

50.1

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

56.3

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

57.6

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

74.3

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

76.8

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

90.2

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

130

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

136

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

236

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

257

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

676

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

745

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

1.8

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

2.6

-

fludarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

3

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

6.4

-

fludarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

50.1

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

56.3

-

clofarabine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

57.6

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

74.3

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

76.8

-

clofarabine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

90.2

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

130

-

cladribine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

136

-

cladribine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

236

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate ATP

Homo sapiens

257

-

deoxycytidine

pH 7.6, 37°C, wild-type enzyme, with co-substrate UTP

Homo sapiens

676

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate ATP

Homo sapiens

745

-

deoxycytidine

pH 7.6, 37°C, enzyme mutant S74E, with co-substrate UTP

Homo sapiens

739449

Koduvayur

Targeted delivery of deoxycyti ...

Homo sapiens

PLoS ONE

11

e0157114

2016

-

1

-

1

-

1

-

1

-

4

-

1

-

1

-

1

-

1

-

4

-

1

-

738175

Yamanishi

Melatonin overcomes resistance ...

Homo sapiens

Exp. Hematol.

43

207-214

2015

-

1

-

1

-

2

-

2

-

1

-

2

-

2

-

739431

Coulibaly

Potent sensitisation of cancer ...

Homo sapiens

PLoS ONE

10

e0140741

2015

-

1

-

3

-

1

-

2

-

1

-

1

-

3

1

-

3

-

1

-

3

-

1

-

1

-

1

-

3

1

-

3

-

3

737326

Muthu

Redesigning human 2'-deoxycyti ...

Homo sapiens

ACS Chem. Biol.

9

2326-2333

2014

-

1

19

-

2

-

1

-

2

-

1

-

1

19

-

1

-

2

-

737347

Nomme

Structural characterization of ...

Homo sapiens

Acta Crystallogr. Sect. D

70

68-78

2014

-

1

-

4

-

1

-

2

-

2

-

1

-

10

1

-

4

-

1

-

1

-

4

-

1

-

2

-

1

-

10

1

-

738770

Hao

-

Facile method for determinatio ...

Homo sapiens

J. Food Drug Anal.

22

236-241

2014

-

1

-

1

-

5

-

1

-

1

-

5

-

1

-

738924

Gao

-

Expression and enzymatic activ ...

Bombyx mori

J. Pure Appl. Microbiol.

8

1837-1844

2014

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

721278

Stalhandske

Homogeneous assay for real-tim ...

Homo sapiens

Anal. Biochem.

432

155-164

2013

-

1

-

1

-

4

-

2

-

1

-

1

-

1

-

1

-

1

-

1

-

2

-

1

-

1

-

722221

Weng

Hypoxia-induced deoxycytidine ...

Homo sapiens, Mus musculus

FASEB J.

27

2013-2026

2013

-

2

-

1

-

6

-

3

-

3

-

2

-

1

-

3

-

3

-

2

4

2

-

738410

Fan

Deoxycytidine kinase promotes ...

Homo sapiens

Int. J. Clin. Exp. Pathol.

6

2733-2744

2013

-

3

-

3

-

3

-

1

-

738829

Murphy

Development of new deoxycytidi ...

Homo sapiens

J. Med. Chem.

56

6696-6708

2013

-

1

-

33

-

1

-

1

-

2

-

4

-

7

-

1

-

7

33

4

-

1

-

2

-

721556

Amsailale

Phosphorylation of deoxycytidi ...

Homo sapiens

Biochem. Pharmacol.

84

43-51

2012

1

-

1

-

1

16

1

-

12

-

1

-

1

-

4

-

13

-

1

-

16

1

-

2

8

-

1

-

2

-

1

-

1

8

16

1

-

12

-

1

-

4

-

13

-

1

-

16

1

-

1

-

16

723235

Neschadim

Cell fate control gene therapy ...

Homo sapiens

Mol. Ther.

20

1002-1013

2012

-

1

-

5

-

2

-

1

-

5

-

1

-

723298

Yang

Deoxycytidine kinase regulates ...

Homo sapiens

Nucleic Acids Res.

40

9621-9632

2012

1

-

3

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

3

-

1

-

1

-

1

-

1

-

1

-

1

-

723345

Ohmine

Attenuation of phosphorylation ...

Homo sapiens

Pharm. Res.

29

2006-2016

2012

-

1

-

2

-

1

-

3

-

3

-

1

-

1

-

1

-

1

-

1

-

2

-

3

-

3

-

1

-

1

-

2

-

721636

Hazra

Post-translational phosphoryla ...

Homo sapiens

Biochemistry

50

2870-2880

2011

-

1

4

-

1

-

1

-

2

-

2

-

1

-

2

-

1

-

1

-

2

-

1

2

1

4

-

1

-

1

-

2

-

1

-

2

-

1

-

1

-

2

-

721969

Nagai

Deoxycytidine kinase modulates ...

Homo sapiens

Cancer Res.

71

1781-1791

2011

1

-

1

-

1

-

1

-

1

-

1

-

11

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

11

1

-

1

-

1

-

704730

Yu

Novel potent inhibitors of deo ...

Homo sapiens

J. Biomol. Screen.

15

72-79

2010

-

1

-

2

1

-

1

-

1

-

1

-

8

-

1

-

2

-

1

-

2

-

1

-

1

-

1

-

8

-

1

-

706027

Funamizu

Is the resistance of gemcitabi ...

Homo sapiens

Oncol. Rep.

23

471-475

2010

-

1

-

4

-

2

-

1

-

1

-

4

-

2

-

706844

Mirzaee

Differences in cytosolic and m ...

Mus musculus, Rattus norvegicus

Toxicology

267

159-164

2010

-

2

-

2

-

2

-

32

-

4

-

2

-

2

-

2

-

2

-

2

-

2

-

32

-

4

-

2

-

2

-

2

-

721622

Hazra

Structural and kinetic charact ...

Homo sapiens

Biochemistry

49

6784-6790

2010

-

1

4

-

1

-

2

-

2

-

1

-

13

-

1

-

1

-

1

-

1

4

-

1

-

2

-

1

-

13

-

1

-

1

-

1

-

722913

Hazra

The sugar ring of the nucleosi ...

Homo sapiens

J. Med. Chem.

53

5792-5800

2010

-

1

-

1

-

6

-

2

-

7

-

2

-

2

1

-

1

-

6

-

7

-

723029

Shu

Novel PET probes specific for ...

Homo sapiens, Mus musculus, Mus musculus C57/BL6J

J. Nucl. Med.

51

1092-1098

2010

-

2

-

4

2

-

9

-

65

-

1

-

23

-

2

-

2

-

2

-

2

-

2

-

4

2

-

9

-

1

-

23

-

2

-

2

-

3

-

723303

Smal

Influence of phosphorylation o ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

29

404-407

2010

-

1

-

6

-

1

-

1

-

1

-

1

-

6

-

1

-

1

-

1

-

723637

Toy

Requirement for deoxycytidine ...

Mus musculus

Proc. Natl. Acad. Sci. USA

107

5551-5556

2010

-

1

-

1

-

2

-

4

-

2

-

1

-

1

-

4

-

2

-

3

-

702271

Hazra

Extending thymidine kinase act ...

Homo sapiens

Biochemistry

48

1256-1263

2009

-

1

2

-

19

1

-

4

-

2

-

1

-

6

-

19

-

1

-

1

2

-

19

1

-

4

-

1

-

6

-

19

-

19

702603

Tarver

5-Fluorocytosine derivatives a ...

Mus musculus

Bioorg. Med. Chem. Lett.

19

6780-6783

2009

-

33

-

3

-

1

-

1

-

1

-

33

-

1

-

33

-

1

-

1

-

702604

Jessop

Lead optimization and structur ...

Homo sapiens

Bioorg. Med. Chem. Lett.

19

6784-6787

2009

-

23

-

1

-

1

-

1

-

25

-

1

-

25

23

-

1

-

703020

Costantino

The role of HuR in gemcitabine ...

Homo sapiens

Cancer Res.

69

4567-4572

2009

-

2

-

1

-

2

-

1

-

1

-

1

-

2

-

2

-

2

-

704900

Shord

Paclitaxel alters the expressi ...

Homo sapiens

J. Exp. Clin. Cancer Res.

28

76

2009

1

-

3

-

3

-

2

-

1

-

1

-

1

-

3

-

2

-

1

-

1

-

690454

Ohhashi

Down-regulation of deoxycytidi ...

Homo sapiens

Anticancer Res.

28

2205-2212

2008

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

690954

Iyidogan

Systematic exploration of acti ...

Homo sapiens

Biochemistry

47

4711-4720

2008

-

11

-

45

-

2

-

28

-

8

-

44

-

11

-

45

-

28

-

8

-

44

-

691590

Szatmari

Adenoviral vector transduction ...

Homo sapiens

Cancer Gene Ther.

15

154-164

2008

-

1

-

6

-

1

-

692040

Kocabas

Gemcitabine pharmacogenomics: ...

Homo sapiens

Drug Metab. Dispos.

36

1951-1959

2008

-

1

-

1

-

1

-

2

-

1

-

1

-

1

-

1

-

1

-

692364

McSorley

Mimicking phosphorylation of S ...

Homo sapiens

FEBS Lett.

582

720-724

2008

-

1

-

4

-

10

1

-

1

-

2

-

1

-

5

1

-

23

-

1

-

4

-

10

1

-

1

-

1

-

5

1

-

23

-

693554

Sabini

Elucidation of different bindi ...

Homo sapiens

J. Med. Chem.

51

4219-4225

2008

-

1

-

6

-

2

-

6

-

6

-

1

-

6

-

6

-

6

-

694483

Joachims

Inhibition of deoxynucleoside ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

27

816-820

2008

-

1

-

1

-

2

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

703425

Kim

Twenty novel genetic variation ...

Homo sapiens

Drug Metab. Pharmacokinet.

23

379-384

2008

-

1

-

2

-

3

-

1

-

1

-

1

-

3

-

671801

Fyrberg

Cell cycle effect on the activ ...

Homo sapiens

Biochem. Biophys. Res. Commun.

357

847-853

2007

-

1

-

2

-

4

-

2

-

1

-

4

-

2

-

672894

Smal

Positive regulation of deoxycy ...

Homo sapiens

Cancer Lett.

253

68-73

2007

5

2

1

-

1

-

2

-

1

-

1

-

3

-

3

-

1

-

5

2

1

-

1

-

2

-

1

-

3

-

3

-

675605

Lamba

Pharmacogenetics of deoxycytid ...

Homo sapiens

J. Pharmacol. Exp. Ther.

323

935-945

2007

-

1

-

4

-

3

-

1

-

1

-

3

-

2

-

2

-

1

-

7

-

3

-

1

-

1

-

2

-

2

-

676221

Sabini

Structural basis for activatio ...

Homo sapiens

Nucleic Acids Res.

35

186-192

2007

-

1

-

15

-

1

-

3

-

3

-

1

-

15

-

23

-

2

-

1

2

-

15

-

1

-

3

-

1

-

15

-

23

-

690229

Soriano

Structures of human deoxycytid ...

Homo sapiens

Acta Crystallogr. Sect. D

63

1201-1207

2007

-

1

-

2

-

1

-

1

-

690849

Rylova

Expression of deoxynucleoside ...

Mus musculus

Biochem. Pharmacol.

74

169-175

2007

-

3

-

2

-

2

-

693531

Sabini

Nonenantioselectivity property ...

Homo sapiens

J. Med. Chem.

50

3004-3014

2007

-

1

-

3

-

1

-

671043

Zhang

The structure of human deoxycy ...

Homo sapiens

Acta Crystallogr. Sect. D

62

133-139

2006

-

1

-

4

-

2

-

1

-

4

1

-

1

-

1

-

4

-

1

-

4

1

-

672137

Mani

Fluorescence energy transfer s ...

Homo sapiens

Biochemistry

45

3534-3541

2006

-

1

-

2

-

8

-

1

-

2

-

1

-

3

-

1

-

2

-

8

-

1

-

1

-

3

-

672149

Godsey

Structural basis for the prefe ...

Homo sapiens

Biochemistry

45

452-461

2006

-

1

-

21

-

1

7

-

2

-

1

-

7

1

-

24

-

2

-

1

2

1

-

21

-

1

7

-

1

-

7

1

-

24

-

672797

Pauwels

The relation between deoxycyti ...

Homo sapiens

BMC Cancer

6

142

2006

-

1

-

2

-

8

-

2

-

1

-

8

-

2

-

672879

Bierau

Cyclopentenyl cytosine-induced ...

Homo sapiens

Cancer Chemother. Pharmacol.

57

105-113

2006

1

-

1

-

2

-

3

-

1

-

1

-

1

-

3

-

1

-

673119

Sebastiani

Immunohistochemical and geneti ...

Homo sapiens

Clin. Cancer Res.

12

2492-2497

2006

-

1

-

1

-

2

-

10

-

1

-

1

-

1

-

10

-

1

-

674748

Smal

Identification of in vivo phos ...

Homo sapiens

J. Biol. Chem.

281

4887-4893

2006

-

1

-

8

-

1

-

2

13

-

2

-

1

-

3

-

14

1

-

1

-

8

-

1

-

1

-

2

13

-

1

-

3

-

14

1

-

676242

Sigmond

Enhanced activity of deoxycyti ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

25

1177-1180

2006

1

-

2

-

1

-

1

-

1

-

3

-

1

-

2

-

1

-

1

-

3

-

676245

Fyrberg

Cell cycle dependent regulatio ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

25

1201-1204

2006

-

1

-

1

-

1

-

1

-

1

-

660812

Keszler

Activation of deoxycytidine ki ...

Homo sapiens

Arch. Biochem. Biophys.

436

69-77

2005

9

-

1

-

1

-

2

-

1

-

2

1

-

4

-

1

-

1

-

9

-

1

-

1

-

1

-

2

-

2

1

-

4

-

1

-

661040

Rylova

Activity profiles of deoxynucl ...

Homo sapiens

Biochem. Pharmacol.

69

951-960

2005

-

1

-

1

-

2

-

3

2

-

1

-

1

-

1

-

1

-

1

-

3

2

-

1

-

1

-

661330

Johnsamuel

Docking simulation with a puri ...

Homo sapiens

Bioorg. Med. Chem.

13

4160-4167

2005

-

1

-

1

-

2

-

2

-

1

-

6

-

1

-

1

-

1

-

2

-

6

-

662521

Hubeek

Immunocytochemical detection o ...

Homo sapiens

J. Clin. Pathol.

58

695-699

2005

-

1

-

3

-

3

-

7

-

3

-

1

-

1

-

1

-

3

-

7

-

3

-

661034

Feng

Anabolism of amdoxovir: phosph ...

Homo sapiens

Biochem. Pharmacol.

68

1879-1888

2004

-

1

-

1

-

6

-

2

-

1

-

1

-

1

-

1

-

2

-

661731

Piskur

Animal deoxyribonucleoside kin ...

Homo sapiens, Mus musculus

FEBS Lett.

560

3-6

2004

-

2

-

2

-

8

-

2

-

8

-

2

-

2

-

2

-

2

-

8

-

8

-

662988

Mani

Fluorescence studies of substr ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

23

1343-1346

2004

-

1

-

1

-

7

-

2

-

22

-

2

1

-

2

-

1

-

1

-

7

-

22

-

662989

Hubeek

Immunocytochemical detection o ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

23

1351-1356

2004

-

1

-

3

-

1

-

3

1

-

4

-

1

-

1

-

1

-

1

-

3

-

3

1

-

4

-

1

-

662992

Al-Madhoun

Phosphorylation of isocarbosty ...

Homo sapiens

Nucleosides Nucleotides Nucleic Acids

23

1865-1874

2004

-

2

3

1

-

1

-

2

-

1

-

4

-

1

-

2

1

-

1

-

1

-

2

3

1

-

1

-

1

-

4

-

1

-

2

1

-

641957

Csapo

Activation of deoxycytidine ki ...

Homo sapiens

Biochem. Pharmacol.

65

2031-2039

2003

2

-

1

-

3

-

1

-

2

-

2

-

1

-

1

-

2

-

641966

Mani

Hydrodynamic and spectroscopic ...

Homo sapiens

Nucleosides, Nucleotides Nucleic Acids

22

175-192

2003

-

2

-

2

-

1

-

1

-

1

-

2

-

1

-

1

-

641970

Someya

Phosphorylation of 4'-thio-bet ...

Homo sapiens

J. Pharmacol. Exp. Ther.

304

1314-1322

2003

-

4

7

-

1

-

2

-

5

-

4

-

4

-

7

-

1

-

5

-

641973

Keszler

Selective activation of deoxyc ...

Homo sapiens

Biochem. Pharmacol.

65

563-571

2003

1

-

2

-

2

-

1

-

2

-

663023

Van Rompay

Substrate specificity and phos ...

Homo sapiens

Pharmacol. Ther.

100

119-139

2003

-

1

-

2

1

-

7

-

1

-

6

-

15

-

2

-

1

2

-

2

1

-

7

-

6

-

15

-

671908

Van den Neste

Activation of deoxycytidine ki ...

Homo sapiens

Biochem. Pharmacol.

65

573-580

2003

4

-

1

-

1

-

1

-

1

-

2

-

2

-

1

-

4

-

1

-

1

-

1

-

1

-

2

-

2

-

671911

Smal

Activation of deoxycytidine ki ...

Homo sapiens

Biochem. Pharmacol.

69

95-103

2003

6

-

3

-

9

-

1

-

1

-

2

-

10

-

2

-

6

-

2

-

3

-

9

-

1

-

2

-

10

-

641955

Beausejour

Cytotoxic activity of 2',2'-di ...

Mus musculus

Biochem. Biophys. Res. Commun.

293

1478-1484

2002

-

1

-

3

-

1

-

661453

Eriksson

Structure and function of cell ...

Homo sapiens

Cell. Mol. Life Sci.

59

1327-1346

2002

-

1

-

1

2

1

-

2

-

1

-

1

-

1

-

7

1

-

22

1

-

3

-

1

3

-

1

-

1

2

1

-

2

-

1

-

7

1

-

22

1

-

641954

Csapo

Activation of deoxycytidine ki ...

Homo sapiens

Biochem. Pharmacol.

61

191-197

2001

1

-

2

-

1

-

2

-

1

-

1

-

2

-

641972

Csapo

Modulation of human deoxycytid ...

Homo sapiens

Acta Biochim. Pol.

48

251-256

2001

-

2

-

641969

Spasokoukotskaja

Effect of phosphorylation on d ...

Homo sapiens

Adv. Exp. Med. Biol.

486

281-285

2000

-

1

-

1

-

1

-

1

-

1

-

640557

Gaubert

Low enantioselectivities of hu ...

Homo sapiens

Biochimie

81

1041-1047

1999

-

2

-

1

-

1

-

641956

Spasokoukotskaja

Treatment of normal and malign ...

Homo sapiens

Eur. J. Cancer

35

1862-1867

1999

6

-

1

-

2

-

3

-

6

-

1

-

3

-

641959

Wang

Stereoisomeric selectivity of ...

Homo sapiens

Biochemistry

38

16993-16999

1999

-

3

-

1

-

1

-

641965

Kierdaszuk

Substrate/inhibitor properties ...

Homo sapiens

Nucleosides Nucleotides

18

1883-1903

1999

-

4

-

2

-

2

-

12

-

4

-

4

-

2

-

12

-

641971

Shafiee

-

Study of human deoxycytidine k ...

Homo sapiens

Eur. J. Med. Chem.

34

423-431

1999

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

1

-

641960

Hatzis

The intracellular localization ...

Homo sapiens

J. Biol. Chem.

273

30239-30243

1998

-

2

-

2

-

2

-

641968

Spasokoukotskaja

Activation of deoxycytidine ki ...

Homo sapiens

Adv. Exp. Med. Biol.

431

641-645

1998

4

-

2

-

2

-

4

-

2

-

641958

Hughes

Kinetic analysis of human deox ...

Homo sapiens

Biochemistry

36

7540-7547

1997

1

-

4

5

-

2

-

1

-

3

-

4

-

1

-

4

5

-

3

-

641961

Usova

The effects of high salt conce ...

Homo sapiens

Eur. J. Biochem.

248

762-766

1997

1

-

1

-

2

-

2

-

1

-

1

-

1

-

2

-

1

-

641963

Eriksson

-

Substrate specificities, expre ...

Homo sapiens

Nucleosides Nucleotides

16

653-659

1997

-

1

-

1

-

1

-

5

-

1

-

1

-

5

-

641964

Shafiee

-

Study of the enantioselectivit ...

Homo sapiens

Nucleosides Nucleotides

16

1767-1770

1997

-

1

-

1

-

1

-

1

-

1

-

641953

Johansson

Differences in kinetic propert ...

Homo sapiens, Mus musculus

Biochem. Pharmacol.

50

163-168

1995

-

2

-

2

20

-

5

-

10

-

2

-

2

-

20

-

10

-

641967

Kim

-

Purification of deoxycytidine ...

Homo sapiens

J. Biochem. Mol. Biol.

28

281-289

1995

-

2

-

1

-

2

-

3

1

-

2

-

2

-

3

1

-

640566

Ikeda

Heterodimeric deoxynucleoside ...

Lactobacillus acidophilus

Biochemistry

33

5328-5334

1994

-

1

2

-

1

-

1

-

4

1

-

1

2

-

1

-

4

1

-

641938

Wang

Purification and characterizat ...

Homo sapiens

Biochim. Biophys. Acta

1202

309-316

1993

5

-

14

3

2

-

2

-

2

-

1

-

3

2

-

23

1

-

5

-

14

-

3

2

-

2

-

1

-

3

2

-

23

1

-

641946

Shewach

Nucleotide specificity of huma ...

Homo sapiens

Mol. Pharmacol.

42

518-524

1992

-

1

-

2

-

2

-

6

-

1

-

2

-

6

-

641939

Eriksson

Characterization of human deox ...

Homo sapiens

FEBS Lett.

280

363-366

1991

-

2

-

2

1

-

1

-

2

1

-

1

-

641947

Habteyesus

Deoxynucleoside phosphorylatin ...

Aotus trivirgatus, Homo sapiens, Mus musculus

Biochem. Pharmacol.

42

1829-1836

1991

-

9

-

1

3

-

7

-

1

-

12

-

10

2

-

9

-

1

3

-

1

-

12

-

10

2

-

641937

Kierdaszuk

Selective inactivation of the ...

Homo sapiens

Biochemistry

29

4109-4114

1990

3

-

2

1

-

1

-

1

-

3

-

3

-

1

6

-

1

3

-

3

-

2

-

1

-

1

-

1

-

1

-

3

-

1

6

-

1

3

-

641940

Kim

Human deoxycytidine kinase: ki ...

Homo sapiens

Biochemistry

28

9043-9047

1989

-

2

1

-

1

-

2

-

1

-

1

-

2

-

1

-

2

-

1

-

1

-

1

-

2

-

1

-

641941

Datta

Kinetic properties and inhibit ...

Homo sapiens

J. Biol. Chem.

264

9359-9364

1989

-

22

6

-

1

-

2

-

1

-

3

1

-

6

-

1

-

22

-

6

-

1

-

1

-

3

1

-

6

-

1

-

641942

Datta

Human T-lymphoblast deoxycytid ...

Homo sapiens

Biochemistry

28

114-123

1989

-

2

11

5

-

8

2

-

3

-

1

-

3

4

1

11

1

-

1

-

2

-

11

-

5

-

8

2

-

1

-

3

4

1

11

1

-

1

-

641943

Bohman

Deoxycytidine kinase from huma ...

Homo sapiens

Biochemistry

27

4258-4265

1988

1

-

4

5

1

2

-

2

-

1

-

4

1

2

7

1

-

1

-

1

-

4

-

5

1

2

-

1

-

4

1

2

7

1

-

1

-

641944

Kim

Affinity purification of human ...

Homo sapiens

Biochem. Biophys. Res. Commun.

156

92-98

1988

-

3

-

1

-

2

-

1

-

1

-

10

1

-

3

-

1

-

1

-

1

-

10

1

-

641079

Yamada

Purine nucleoside kinases in h ...

Homo sapiens

Biochim. Biophys. Acta

761

34-40

1983

-

15

3

1

-

2

-

5

-

4

-

15

-

3

1

-

5

-

4

-

641936

Ives

Deoxycytidine kinase from calf ...

Bos taurus

Methods Enzymol.

51

337-345

1978

-

3

5

1

8

1

-

1

-

1

-

1

2

7

-

1

-

1

-

1

-

3

-

5

-

1

8

1

-

1

-

1

2

7

-

1

-

1

-

1

-

641945

Baxter

A general method for purificat ...

Bos taurus, Homo sapiens, Sus scrofa

Biochem. J.

173

1005-1008

1978

-

3

-

4

-

3

-

8

-

3

-

3

-

3

-

3

-

8

-

3

-

3

-

641950

Deibler

Deoxynucleoside kinases from L ...

Lactobacillus acidophilus

J. Biol. Chem.

252

8240-8244

1977

-

9

1

-

1

-

1

-

1

-

5

-

9

-

1

-

1

-

5

-

641933

Meyers

Purification of deoxycytidine ...

Mus musculus

Arch. Biochem. Biophys.

177

10-15

1976

1

-

1

-

2

1

-

1

-

1

-

2

-

2

-

1

-

2

-

1

-

1

-

2

1

-

1

-

2

-

2

-

1

-

2

-

641935

Krenitsky

Deoxycytidine kinase from calf ...

Bos taurus

J. Biol. Chem.

251

4055-4061

1976

-

6

3

-

1

-

1

-

1

-

11

-

1

-

6

-

3

-

1

-

1

-

11

-

1

-

641948

Coleman

Deoxycytidine kinase: properti ...

Homo sapiens

Blood

46

791-803

1975

-

3

2

-

1

-

2

-

1

-

2

-

4

-

3

-

2

-

1

-

1

-

2

-

4

-

641949

Leung

Mitochondrial and herpesvirus- ...

Aotus trivirgatus, Gallus gallus, Mus musculus

J. Virol.

16

486-497

1975

-

9

-

3

-

3

-

3

-

9

-

3

-

3

-

677714

Wachsman

Demonstration of a deoxycytidi ...

Bacillus megaterium, Bacillus megaterium KM / ATCC 13632

Appl. Microbiol.

25

506-508

1973

-

1

-

12

-

12

-

1

-

12

-

641934

Kozai

Metabolism in deoxyribonucleot ...

Bos taurus

J. Biochem.

71

485-496

1972

-

21

3

1

5

-

1

-

1

-

1

-

13

-

1

-

1

-

21

-

3

1

5

-

1

-

1

-

13

-

1

-

1

-

641931

Durham

Deoxycytidine kinase. II. Puri ...

Bos taurus

J. Biol. Chem.

245

2276-2284

1970

2

-

1

22

-

10

1

-

1

-

1

-

1

2

9

-

1

-

2

-

1

-

3

-

2

-

1

-

22

-

10

1

-

1

-

1

2

9

-

1

-

2

-

1

-

3

-

641932

Ives

Deoxycytidine kinase. 3. Kinet ...

Bos taurus

J. Biol. Chem.

245

2285-2294

1970

-

3

-

1

-

1

-

1

-

4

-

1

-

3

-

1

-

1

-

4

-

1

-

641929

Kessel

Properties of deoxycytidine ki ...

Mus musculus

J. Biol. Chem.

243

4739-4744

1968

-

2

16

1

6

1

-

1

-

1

-

1

3

6

-

1

2

-

1

-

2

-

16

-

1

6

1

-

1

-

1

3

6

-

1

2

-

1

-

641930

Momparler

Mammalian deoxynucleoside kina ...

Bos taurus

J. Biol. Chem.

243

4298-4304

1968

1

-

8

5

1

3

-

1

-

1

-

1

-

7

-

1

-

1

-

8

-

5

1

3

-

1

-

1

-

7

-

1

-

Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells

Data extracted from this reference: